Haindl Michaela Tanja, Hochmeister Sonja
Department of General Neurology, University Clinic of Neurology, Medical University of Graz, Graz, Austria.
Front Neurol. 2021 Oct 20;12:757795. doi: 10.3389/fneur.2021.757795. eCollection 2021.
Multiple sclerosis is a multifactorial disease of the central nervous system with both genetic and environmental causes. The exact disease mechanisms are still unclear. Consequently, studies of possible treatment and preventive measures cover a large setting of heterogeneous approaches. Vitamin D is one of these approaches, and in many trials the relation of vitamin D serum levels and multiple sclerosis disease risk and activity describes different effects with sometimes inconsistent findings. Animal models are substantial for the research of disease mechanisms, and many of the drugs that are currently in use in multiple sclerosis have been developed, tested, or validated animal studies. Especially when clinical studies show contradicting findings, the use of standardized settings and information about the mechanistic background is necessary. For this purpose, animal models are an essential tool. There is a variety of different experimental settings and types of animal models available, each of them with own strengths but also weaknesses. This mini-review aims to overview results of vitamin D studies in different animal models and sums up the most important recent findings.
多发性硬化症是一种中枢神经系统的多因素疾病,由遗传和环境因素共同导致。确切的疾病机制仍不清楚。因此,对可能的治疗和预防措施的研究涵盖了大量不同的方法。维生素D就是其中一种方法,在许多试验中,维生素D血清水平与多发性硬化症疾病风险和活动之间的关系呈现出不同的影响,有时结果并不一致。动物模型对于疾病机制的研究至关重要,目前许多用于治疗多发性硬化症的药物都是在动物研究中开发、测试或验证的。特别是当临床研究结果相互矛盾时,使用标准化的实验设置和有关机制背景的信息是必要的。为此,动物模型是一种必不可少的工具。有多种不同的实验设置和动物模型类型可供选择,每种都有其自身的优点和缺点。本综述旨在概述不同动物模型中维生素D研究的结果,并总结最近最重要的发现。